Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magnifort (also marketed as Magniforte) is a multi-ingredient dietary supplement developed by Holistica and manufactured by Arian Salamat Sina. It is formulated as an oral capsule containing marine magnesium, thiamine (vitamin B1), pyridoxine (vitamin B6), cholecalciferol (vitamin D3), and menaquinone-7 (vitamin K2-7). Magnifort is designed to support muscle, bone, and nervous system health. It is primarily used to reduce the frequency and severity of muscle cramps and spasms, alleviate neuropathic pain (such as diabetic neuropathy and carpal tunnel syndrome), prevent osteoporosis, and reduce migraine attacks.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Magnifort.